
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
PERSPECTIVE article
Front. Drug Deliv.
Sec. Cardiovascular Drug Delivery
Volume 5 - 2025 | doi: 10.3389/fddev.2025.1564120
This article is part of the Research Topic Modelling of Intravascular Drug Delivery Using Nanocarriers View all 3 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In recent years, there has been a significant increase in literature on emerging nanotechnologies, including nanoparticles, nanorobots, and exosomes, for various therapeutic applications. Additionally, politically driven research initiatives aimed at accelerating COVID-19 vaccine development have further amplified interest in nanoparticles as drug delivery systems. This article provides a personal perspective on the scientific claims surrounding nanoparticles by: (i) analyzing the historical evolution of their terminology, (ii) reviewing the most cited publications in the field, and (iii) offering a professional assessment to guide the next generation of medicinal chemists. A key aspect of this discussion is the stealth effect, which refers to the ability of nanoparticles to evade recognition and clearance by the immune system, thereby prolonging their circulation time in the bloodstream. This property is essential for enhancing the efficacy of nanoparticle-based therapeutics by improving bioavailability and ensuring targeted drug delivery to diseased tissues. Furthermore the continuing improvement in ligand-molecules and other functional tool have developed novel strategies and brand-new definition of delivery systems, such as Trojan Horse and Nanorobots.
Keywords: Nanoparticles, Liposome, IV Treatments, pk, PD, Nano-drugs, Stealth effect, Functionalization tools
Received: 21 Jan 2025; Accepted: 21 Mar 2025.
Copyright: © 2025 Domenico. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fuoco Domenico, Polytechnique Montréal, Montreal, Canada
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.